(1)
Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction . J. Pharm. Nutr. Sci. 2014, 4 (3), 170-176. https://doi.org/10.6000/1927-5951.2014.04.03.1.